Sun Pharma Advanced Research Q3FY21 loss at Rs. 67.62 crore

Sun Pharma Advanced Research Q3FY21 loss at Rs. 67.62 crore

By: IPP Bureau

Last updated : June 08, 2021 11:19 am



The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.


Sun Pharma Advanced Research has reported total income of Rs.23.41 crores during the period ended December 31, 2020 as compared to Rs.20.46 crores during the period ended September 30, 2020.

 

The company reported total income of Rs.20.31 crores during the period ended December 31, 2019.

 

Sun Pharma Advanced Research has posted lossof Rs. 67.62 crores for the period ended December 31, 2020 as against net loss of Rs. 83.49 crores for the period ended September 30, 2020.

 

The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.

 

For during the 9 months period ended December 31, 2020, the company has reported total income of Rs.229.98 crores as compared to Rs.60.75 crores during the 9 months period ended December 31, 2019.

 

Sun Pharma Advanced Research has posted net loss of Rs. 94.42 crores for the 9 months period ended December 31, 2020 as against net loss of Rs.(212.86) crores for the 9 months period ended December 31, 2019.

 

The company has reported EPS of Rs.(3.60) for the 9 months period ended December 31, 2020 as compared to Rs.(8.12) for the 9 months period ended December 31, 2019.

Sun Pharma Advanced Research

First Published : February 11, 2021 8:10 am